Statistical data showed that high FXR expression was positively associated with a more advanced pathological stage (p = 0.012) and T status (p = 0.025), as well as a larger tumor size (p = 0.03) (Table 2), indicating the possible involvement of FXR in tumor growth and NSCLC progression. The gene discussed is NR1H4; the disease is neoplasm.